Literature DB >> 9551731

CD14 expression and soluble CD14 after segmental allergen provocation in atopic asthma.

J C Virchow1, P Julius, H Matthys, C Kroegel, W Luttmann.   

Abstract

Allergic asthma is associated with the recruitment of activated inflammatory cells after allergen challenge. Surface expression of CD14 has been proposed as a marker of cell activation and differentiation. We therefore measured CD14 expression on activated macrophages and granulocytes as well as soluble CD14 (sCD14) concentrations in peripheral blood and bronchoalveolar lavage (BAL) following segmental allergen provocation (SAP) with individually standardized doses of allergen in eight patients with allergic asthma. Two segments of the right lung were challenged with allergen. Two segments of the left lung, into which saline was instilled, served as controls. CD14 expression on macrophages and granulocytes was determined by flow-cytometry and concentrations of interleukins and sCD14 were analysed by enzyme-linked immunosorbent assay (ELISA) 10 min and 18 h after challenge. Soluble CD14 concentrations remained unchanged in BAL fluid after saline challenge and 10 min after SAP, but increased significantly 18 h after SAP. Although macrophage numbers increased 18h after SAP, CD14 expression on these cells did not change. Unlike macrophages, granulocyte numbers correlated with sCD14 levels 18 h after SAP while their CD14 expression decreased significantly. Furthermore, sCD14 correlated with interleukin (IL)-13 concentrations 18 h after SAP. An increase in soluble CD14 can be observed 18 h but not 10 min after segmental allergen provocation suggesting local release of this surface antigen. Our findings imply that CD14-mediated cell activation following segmental allergen provocation could play a role in asthmatic inflammation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9551731     DOI: 10.1183/09031936.98.11020317

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  12 in total

Review 1.  Cytokine expression in allergic inflammation: systematic review of in vivo challenge studies.

Authors:  Manuel A R Ferreira
Journal:  Mediators Inflamm       Date:  2003-10       Impact factor: 4.711

2.  CD14, a key candidate gene associated with a specific immune response to cockroach.

Authors:  P Gao; D N Grigoryev; N M Rafaels; D Mu; J M Wright; C Cheadle; A Togias; T H Beaty; R A Mathias; J T Schroeder; K C Barnes
Journal:  Clin Exp Allergy       Date:  2010-07-04       Impact factor: 5.018

3.  The CD14 C-159T polymorphism is not associated with asthma or asthma severity in an Australian adult population.

Authors:  M-A Kedda; F Lose; D Duffy; E Bell; P J Thompson; J Upham
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

Review 4.  Soluble CD14: role in atopic disease and recurrent infections, including otitis media.

Authors:  Karin C Lødrup Carlsen; Berit Granum
Journal:  Curr Allergy Asthma Rep       Date:  2007-11       Impact factor: 4.806

5.  Early-life co-administration of cockroach allergen and endotoxin augments pulmonary and systemic responses.

Authors:  K Kulhankova; C L S George; J N Kline; J M Snyder; M Darling; E H Field; P S Thorne
Journal:  Clin Exp Allergy       Date:  2009-04-28       Impact factor: 5.018

Review 6.  Effect of pollutants in rhinitis.

Authors:  D B Peden
Journal:  Curr Allergy Asthma Rep       Date:  2001-05       Impact factor: 4.919

Review 7.  Association of CD14 -260 (-159) C>T and asthma: a systematic review and meta-analysis.

Authors:  Linlu Zhao; Michael B Bracken
Journal:  BMC Med Genet       Date:  2011-07-11       Impact factor: 2.103

Review 8.  Work-related asthma and implications for the general public.

Authors:  Edward L Petsonk
Journal:  Environ Health Perspect       Date:  2002-08       Impact factor: 9.031

Review 9.  Pollutants and asthma: role of air toxics.

Authors:  David B Peden
Journal:  Environ Health Perspect       Date:  2002-08       Impact factor: 9.031

10.  The neurotrophins nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4 are survival and activation factors for eosinophils in patients with allergic bronchial asthma.

Authors:  Christina Nassenstein; Armin Braun; Veit Johannes Erpenbeck; Marek Lommatzsch; Stephanie Schmidt; Norbert Krug; Werner Luttmann; Harald Renz; Johann Christian Virchow
Journal:  J Exp Med       Date:  2003-08-04       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.